UK Medical Devices Agency (MDA) praises Amerlite Processing Center
This article was originally published in Clinica
Executive Summary
Johnson & Johnson's automated Amerlite Processing Center is a significant advance on the previous system, says a UK Medical Devices Agency evaluation. The reviewers did experience some assay problems but said these would only affect a few samples. Most kits showed robustness and good calibration curve stability for at least six weeks. All except the oestradiol assay had imprecision under 10% and heterophilic antibodies only affected tests at high concentrations.